Diagnostic and treatment assembly
Abstract
A diagnostic and treatment assembly, configured to diagnose and treat cellular disease. The diagnostic and treatment assembly has a radio wave generator communicatively coupled to a carrier modulator and a radio wave amplifier. An impedance matching system is electrically coupled to the radio wave amplifier. A reflected wave sensor is electrically coupled to the impedance matching system. A radiator applicator is electrically coupled to the reflected wave sensor. A vector impedance analyzer is electrically coupled to the radio wave amplifier. An information collector data network is electrically coupled to the vector impedance analyzer. A data logger is communicatively coupled to the carrier modulator, the vector impedance analyzer, and the reflected wave sensor. The diagnostic and treatment assembly operates in a low-power mode to diagnose a cellular disease and in a high-power mode to treat the cellular disease.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of analyzing a suspected biological sample to determine the frequency to identify a virus in said suspected biological sample comprising of:
a. collecting a reference biological sample that does not have the virus and placing it in a first container; b. collecting said suspected biological sample and placing said suspected biological sample in a second container; c. exposing said reference biological sample in said first container to radio waves; d. said radio waves having a radio wave frequency; e. exposing said suspected biological sample in said second container to radio wave frequency; f. measuring the energy absorption of said radio wave frequency of said suspected biological sample in said second container; g. measuring the phase of said reference biological sample in said first container; h. measuring the magnetic reluctance of said reference biological sample in said first container; i. using said radio wave frequency of said suspected biological sample in said second container and said phase of said reference biological sample and said magnetic reluctance of said reference biological sample in said first container; and j. determining the fundamental frequency.
2 . The method of analyzing said suspected biological sample of claim 1 wherein the virus is selected from the group consisting of Influenza, Coronavirus, Sars-Cov-2, HIV, Herpes, Dengue and Zika.
3 . The method of analyzing said suspected biological sample of claim 1 wherein said radio waves frequency is selected from the group consisting of 1500 Terahertz (THz) to 150 THz.
4 . The method of analyzing said suspected biological sample of claim 1 wherein said radio waves frequency is preferably 920 THz.
5 . The method of analyzing said suspected biological sample of claim 1 wherein said radio waves frequency is a fundamental frequency to resonate with the structure.
6 . The method of analyzing said suspected biological sample of claim 1 wherein said energy absorption of said reference biological sample in said container is a stored value.Join the waitlist — get patent alerts
Track US2021364538A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.